A randomised, prospective comparison of Sevoflurane Versus Desflurane using minimal flow anaesthesia
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/10/058239
- Lead Sponsor
- Fortis Hospital, Mulund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American Society of Anaesthesiology - Physical Status 1 and 2,
Elective surgery under general endotracheal anaesthesia
Duration 120 -240 minutes
Exclusion Criteria
Patients who require surgery under emergency conditions
Patients addicted to alcohol or other drugs
Patients with coronary heart disease, chronic obstructive pulmonary disease, congestive heart failure, or kidney disease, and obese patients (BMI >30)
Pregnant patients
Patients undergoing supra-major surgeries undergoing major hemodynamic changes and fluid shifts.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the consumption of inhalational agent used in each groupTimepoint: 120 - 240 minutes
- Secondary Outcome Measures
Name Time Method Time to achieve MAC 0.7 <br/ ><br>Body Temperature <br/ ><br>Hemodynamic parameters (HR, SBP, DBP, MAP) & SpO2 <br/ ><br>Depth of Anaesthesia (MAC) <br/ ><br>Gas Analysis (FiO2, FeO2, FiAgent, FeAgent, ETCO2, FiCO2) <br/ ><br>Minute ventilation. <br/ ><br>Time to extubation <br/ ><br>Time to discharge from PACU (Modified Aldrete score) <br/ ><br>To compare the cost-effectiveness of the inhalational agent in each group. <br/ ><br>Timepoint: 120-240 minutes